CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Compute-in-memory (CIM) is being widely explored to minimize power consumption related to data movement and multiply-and-accumulate (MAC) operations for AI edge devices. Compared to analog based CIMs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results